Literature DB >> 8845308

Induction of stathmin expression during erythropoietic differentiation.

T Rabilloud1, R Berthier, C Valette, J Garin, J J Lawrence.   

Abstract

Stathmin is a M(r) 19,000 cytosolic protein proposed to act as a relay for signal-activating pathways regulating cell proliferation and differentiation. In a study of erythropoietic differentiation, stathmin was detected as a protein that is induced during the early stages of differentiation in several cellular model systems. The unphosphorylated form of stathmin was most prominently induced, which suggests that this form does not only play a role in pathways oriented toward cell proliferation, as is the case for lymphocytic systems, but may also play a role in various differentiation pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845308

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  4 in total

1.  cAMP-dependent phosphorylation and hexamethylene-bis-acetamide induced dephosphorylation of p19 in murine erythroleukemia cells.

Authors:  J S Scheele
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

2.  Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells.

Authors:  João Agostinho Machado-Neto; Paula de Melo Campos; Patricia Favaro; Mariana Lazarini; Adriana da Silva Santos Duarte; Irene Lorand-Metze; Fernando Ferreira Costa; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  Oncotarget       Date:  2015-10-06

3.  Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells.

Authors:  João Agostinho Machado-Neto; Ana Paula Nunes Rodrigues Alves; Jaqueline Cristina Fernandes; Juan Luiz Coelho-Silva; Renata Scopim-Ribeiro; Bruna Alves Fenerich; Fernanda Borges da Silva; Priscila Santos Scheucher; Belinda Pinto Simões; Eduardo Magalhães Rego; Fabiola Traina
Journal:  Heliyon       Date:  2017-09-28

Review 4.  Stathmin 1 in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  BMB Rep       Date:  2014-12       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.